Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

High risk of recurrence/progression bladder tumours is treated with Bacillus Calmette-Guérin (BCG) immunotherapy after complete resection of the tumour. Approximately 75% of these tumours express the uncommon carbohydrate antigen sialyl-Tn (Tn), a surrogate biomarker of tumour aggressiveness. Such c...

ver descrição completa

Detalhes bibliográficos
Autor principal: Lima, Luís (author)
Outros Autores: Severino, Paulo (author), Silva, Mariana (author), Miranda, Andreia (author), Tavares, Ana (author), Pereira, Sofia (author), Fernandes, Elisabete (author), Cruz, Ricardo (author), Amaro, Teresina (author), Reis, Celso (author), Dall'Olio, Fabio (author), Amado, Francisco (author), Videira, Paula (author), Santos, Lúcio (author), Ferreira, José Alexandre (author)
Formato: article
Idioma:eng
Publicado em: 2013
Assuntos:
Bacillus Calmette-Guerin
BCG immunotherapy
Bladder Cancer
Sialyl-Tn
Sialyl-6-T
Tumor glycosylation
Texto completo:http://hdl.handle.net/10400.22/3171
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/3171

Texto Completo

http://hdl.handle.net/10400.22/3171

Registros relacionados